What question did this study set out to answer?

This study aims to evaluate the impact of early tirofiban administration before primary angioplasty on angiographic outcomes in acute myocardial infarction.

March 24, 2003CirculationOpen Access

Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes

View Full Paper

Ask AI

Bookmark

Why the study?

Does early administration of tirofiban in the emergency room improve angiographic outcomes in patients presenting with acute myocardial infarction undergoing primary angioplasty?

Population

n=100 patients presenting with acute myocardial infarction undergoing planned primary angioplasty

Comparison

Early administration of tirofiban in the… vs Later administration of tirofiban in the…

Design

RCT, randomized

Follow-up

30-day

Authors

DLDavid P. LeeGeneral Cardiology NHNiall HerityBelfast Health and Social Care Trust BHBonnie L. HiattSinai Hospital

Discussion

Member takes

Implication

Supports early tirofiban in the ER for STEMI; extends randomized evidence for upstream GP IIb/IIIa use.

Key Points

This study aims to evaluate the impact of early tirofiban administration before primary angioplasty on angiographic outcomes in acute myocardial infarction.
Single-center randomized trial involving 100 patients with acute myocardial infarction.
Patients received either early tirofiban in the emergency room or later in the catheterization lab.
Primary outcomes included TIMI grade flow, corrected TIMI frame counts, and TIMI grade myocardial perfusion.
Significant improvement in initial TIMI grade flow, corrected TIMI frame counts, and TIMI grade myocardial perfusion with early tirofiban administration.
Rate of 30-day major adverse cardiac events indicated potential benefits for early administration.

Structured PICO

Does early administration of tirofiban in the emergency room improve angiographic outcomes in patients presenting with acute myocardial infarction undergoing primary angioplasty?

Population

n=100 patients presenting with acute myocardial infarction undergoing planned primary angioplasty

Intervention

Early administration of tirofiban in the emergency room before primary angioplasty

Comparator

Later administration of tirofiban in the catheterization laboratory

Outcome

Initial TIMI grade flow, corrected TIMI frame counts, and TIMI grade myocardial perfusion ("blush")surrogate

Early administration of tirofiban in the emergency room before primary angioplasty improves initial angiographic outcomes in patients with acute myocardial infarction.

Cite This Study

Lee et al. (2003) studied this question.

synapsesocial.com/papers/6a701f595d37378ac1dd2fe3 https://doi.org/10.1161/01.cir.0000056120.00513.7a

View Full Paper

Ask AI

Bookmark

Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Adjunctive Platelet Glycoprotein IIb/IIIa Receptor Inhibition With Tirofiban Before Primary Angioplasty Improves Angiographic Outcomes

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider